We observed a significant increase (p < 0.001) in zonulin concentrations in COVID-19 (60 ± 3.9 ng/mL) and PCC patients (64 ± 0.9 ng/mL) when compared with the CTL group (19 ± 3 ng/mL) (Figure 4A). The gene discussed is HP; the disease is COVID-19.